Skip to main content
. 2019 Nov 4;31(3):260–271. doi: 10.1097/CAD.0000000000000865

Fig. 4.

Fig. 4

miR-107 inhibits the proliferation rate of LSCC cells. (a and b) After 48 hours, MTT assay showed that the proliferation rates of TU212 and TU686 cells transfected with agomiR-107, antagomiR-107, and corresponding negative controls were significantly reduced or increased compared with those in the control (*P < 0.05). LSCC, laryngeal squamous cell carcinoma; miR-107, microRNA-107.